title: Effects of orlistat therapy on plasma concentrations of oxygenated and hydrocarbon carotenoids.
abstract: Orlistat is a lipase inhibitor that is applied for treating obesity. Lipases are required for digestion and absorption of dietary lipids and fat-soluble vitamins and carotenoids. The aim of this study was to compare the effects of orlistat therapy on plasma concentrations of oxygenated (beta-cryptoxanthin, lutein/zeaxanthin) and hydrocarbon (alpha-, beta-carotene, lycopene) carotenoids. Six patients with a body mass index (BMI) > or = 30 kg/m2 received 360 mg/d orlistat over 4.5 mon. Plasma carotenoid concentrations were determined at baseline (T0) and after 3 (T3) and 4.5 mon (T4.5) along with anthropometric, dietary, and biochemical indices, including plasma lipids, retinol, (alpha- and gamma-tocopherols, and FA. Baseline BMI was 32.7 +/- 1.97 kg/m2. Five of six patients lost weight; the average weight loss was 3.6 +/- 2.4% (P = 0.47). There were no significant changes in dietary carotenoid intakes. In contrast, plasma alpha- and beta-carotene concentrations decreased significantly from T0 to T4.5 by 45% (P = 0.006) and 32% (P = 0.013), respectively. Plasma lycopene decreased from T0 to T3 but increased again from T3 to T4.5, while beta-cryptoxanthin and lutein/zeaxanthin concentrations did not change. There were no significant alterations in tocopherol, retinol, and FA concentrations. In conclusion, even though weight loss was not significant, orlistat therapy was associated with significant decreases in plasma concentrations of the highly lipophilic hydrocarbon carotenoids, alpha- and beta-carotene.
authors: Human Nutrition & Metabolism Research and Training Center Graz, Institute of Molecular Biosciences, Karl-Franzens University, 8010 Graz, Austria.
authors: Isabella
authors: I
authors: Sundl
authors: Elisabeth
authors: E
authors: Pail
authors: Karin
authors: K
authors: Mellitzer
authors: Hermann
authors: H
authors: Toplak
authors: Brigitte M
authors: BM
authors: Winklhofer-Roob
mesh_terms: D000368:Aged; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D002338:Carotenoids / Q000097:blood*; D065366:Cryptoxanthins; D005260:Female; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D014975:Lutein / Q000097:blood; D000077276:Lycopene; D008297:Male; D008875:Middle Aged; D000077403:Orlistat; D024341:Xanthophylls / Q000097:blood; D065146:Zeaxanthins; D019207:beta Carotene / Q000097:blood
chemical_list: D019440:Anti-Obesity Agents; D065366:Cryptoxanthins; D007783:Lactones; D024341:Xanthophylls; D065146:Zeaxanthins; D019207:beta Carotene; D002338:Carotenoids; C041635:alpha-carotene; D000077403:Orlistat; D000077276:Lycopene; D014975:Lutein
references: Clin Chem. 1972 Jun;18(6):499-502
references: 4337382
references: Methods Enzymol. 1999;299:348-62
references: 9916214
references: JAMA. 1999 Jan 20;281(3):235-42
references: 9918478
references: J Clin Pharmacol. 1996 Jul;36(7):647-53
references: 8844448
references: Annu Rev Nutr. 1993;13:561-87
references: 8369159
references: Free Radic Biol Med. 1995 May;18(5):849-59
references: 7797092
references: JAMA. 1999 Oct 27;282(16):1523-9
references: 10546691
references: Anal Biochem. 1991 Oct;198(1):184-90
references: 1838668
references: JAMA. 2003 Jan 1;289(1):76-9
references: 12503980
references: Diabetes Obes Metab. 2002 Jan;4(1):49-55
references: 11874442
references: Clin Pharmacol Ther. 1999 Sep;66(3):315-22
references: 10511068
references: Am J Clin Nutr. 2002 Jul;76(1):172-9
references: 12081831
references: J Clin Pharmacol. 1994 Nov;34(11):1121-5
references: 7876405
references: Am J Clin Nutr. 1996 Oct;64(4):622-6
references: 8839509
references: Clin Chem. 1997 Jan;43(1):146-53
references: 8990237
references: Am J Epidemiol. 2002 Jun 1;155(11):1023-32
references: 12034581
references: Pharmacotherapy. 2002 Jul;22(7):814-22
references: 12126214
references: Obes Rev. 2003 Feb;4(1):25-42
references: 12608525
references: Am J Clin Nutr. 1995 Dec;62(6 Suppl):1427S-1430S
references: 7495243
references: Lancet. 1998 Jul 18;352(9123):167-72
references: 9683204
references: Eur J Clin Pharmacol. 1998 Apr;54(2):125-32
references: 9626916
references: Pharmacotherapy. 2000 Mar;20(3):270-9
references: 10730683
references: Annu Rev Nutr. 2002;22:483-504
references: 12055355
references: Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21
references: 11753595
references: Atherosclerosis. 1999 May;144(1):117-22
references: 10381285
references: Am J Clin Nutr. 1999 Aug;70(2):261-8
references: 10426704
references: J Nutr. 2005 Jun;135(6):1456-61
references: 15930452